Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors

被引:206
作者
Preitner, F
Ibberson, M
Franklin, I
Binnert, C
Pende, M
Gjinovci, A
Hansotia, T
Drucker, DJ
Wollheim, C
Burcelin, R
Thorens, B
机构
[1] Univ Lausanne, Inst Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland
[2] Univ Geneva, Med Ctr, Dept Internal Med, Div Clin Biochem, CH-1211 Geneva, Switzerland
[3] Inst Physiol, Lausanne, Switzerland
[4] Friedrich Miescher Inst, CH-4002 Basel, Switzerland
[5] Univ Toronto, Toronto Gen Hosp, Banting & Best Diabet Ctr, Dept Med, Toronto, ON M5G 1L7, Canada
关键词
D O I
10.1172/JCI200420518
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The role of the gluco-incretin hormones GIP and GLP-1 in the control of P cell function was studied by analyzing mice with inactivation of each of these hormone receptor genes, or both. Our results demonstrate that glucose intolerance was additively increased during oral glucose absorption when both receptors were inactivated. After intraperitoneal injections, glucose intolerance was more severe in double- as compared to single-receptor KO mice, and euglycemic clamps revealed normal insulin sensitivity, suggesting a defect in insulin secretion. When assessed in vivo or in perfused pancreas, insulin secretion showed a lack of first phase in Glp-1R(-/-) but not in Gipr(-/-) mice. In perifusion experiments, however, first-phase insulin secretion was present in both types of islets. In double-KO islets, kinetics of insulin secretion was normal, but its amplitude was reduced by about 50% because of a defect distal to plasma membrane depolarization. Thus, gluco-incretin hormones control insulin secretion (a) by an acute insulinotropic effect on beta cells after oral glucose absorption (b) through the regulation, by GLP-1, of in vivo first-phase insulin secretion, probably by an action on extra-islet glucose sensors, and (c) by preserving the function of the secretory pathway, as evidenced by a beta cell autonomous secretion defect when both receptors are inactivated.
引用
收藏
页码:635 / 645
页数:11
相关论文
共 46 条
[1]   Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms [J].
Balkan, B ;
Li, X .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 279 (04) :R1449-R1454
[2]   PKA-mediated phosphorylation of the human KATP channel:: separate roles of Kir6.2 and SUR1 subunit phosphorylation [J].
Béguin, P ;
Nagashima, K ;
Nishimura, M ;
Gonoi, T ;
Seino, S .
EMBO JOURNAL, 1999, 18 (17) :4722-4732
[3]   Portal glucose infusion in the mouse induces hypoglycemia - Evidence that the hepatoportal glucose sensor stimulates glucose utilization [J].
Burcelin, R ;
Dolci, W ;
Thorens, B .
DIABETES, 2000, 49 (10) :1635-1642
[4]   Glucose sensing by the hepatoportal sensor is GLUT2-dependent - In vivo analysis in GLUT2-null mice [J].
Burcelin, R ;
Dolci, W ;
Thorens, B .
DIABETES, 2000, 49 (10) :1643-1648
[5]   GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization [J].
Burcelin, R ;
Crivelli, V ;
Perrin, C ;
Da Costa, A ;
Mu, J ;
Kahn, BB ;
Birnbaum, MJ ;
Kahn, CR ;
Vollenweider, P ;
Thorens, B .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1555-1562
[6]   Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor [J].
Burcelin, R ;
Da Costa, A ;
Drucker, D ;
Thorens, B .
DIABETES, 2001, 50 (08) :1720-1728
[7]   GUT HORMONES AND DIABETES-MELLITUS [J].
CREUTZFELDT, W ;
NAUCK, M .
DIABETES-METABOLISM REVIEWS, 1992, 8 (02) :149-177
[8]   GLUCAGONLIKE PEPTIDE-I STIMULATES INSULIN GENE-EXPRESSION AND INCREASES CYCLIC-AMP LEVELS IN A RAT ISLET CELL-LINE [J].
DRUCKER, DJ ;
PHILIPPE, J ;
MOJSOV, S ;
CHICK, WL ;
HABENER, JF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (10) :3434-3438
[9]  
EBERT R, 1987, Diabetes Metabolism Reviews, V3, P1
[10]   Mouse pancreatic β-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene [J].
Flamez, D ;
Van Breusegem, A ;
Scrocchi, LA ;
Quartier, E ;
Pipeleers, D ;
Drucker, DJ ;
Schuit, F .
DIABETES, 1998, 47 (04) :646-652